Glaucoma Articles
This is the place for the latest information about our work here at Glaucoma Research Foundation and for current events in the world of eye health. All breakthroughs and insights are made possible through the dedication of researchers, and through the continued financial support and active involvement of the community.
![Collaborative Research Is Speeding Progress Toward A Cure 1 The Power Of Connection: Peer Support For Glaucoma Patients And Their Loved Ones](https://glaucoma.org/wp-content/uploads/2023/11/senior-woman-in-peer-support-group_900-585x540.jpg)
The Power of Connection: Peer Support for Glaucoma Patients and Their Loved Ones
Whether you’ve recently been diagnosed with glaucoma or are learning how to cope, connecting with others can be helpful and powerful.
![Collaborative Research Is Speeding Progress Toward A Cure 2 Assistive Technology](https://glaucoma.org/wp-content/uploads/2023/11/blind-man-using-assistive-technology_900-585x540.jpg)
Assistive Technology
Assistive devices and technology can help people with low vision and vision loss to participate in daily activities with minimal impairment.
![Collaborative Research Is Speeding Progress Toward A Cure 3 Tips To Help A Child With Glaucoma In The Classroom](https://glaucoma.org/wp-content/uploads/2023/11/student-in-classroom_900-585x540.jpg)
Tips To Help a Child With Glaucoma in the Classroom
If your child has glaucoma or a child in your classroom has it, you may wonder how the condition affects their ability to learn in school.
![Collaborative Research Is Speeding Progress Toward A Cure 4 Can Glaucoma Affect Contrast Sensitivity?](https://glaucoma.org/wp-content/uploads/2023/11/man-with-vision-problems-contrast-sensitivity_900-585x540.jpg)
Can Glaucoma Affect Contrast Sensitivity?
Contrast sensitivity is the eyes’ ability to identify an object not clearly defined from its background.
![Collaborative Research Is Speeding Progress Toward A Cure 5 Santen Receives Fda Approval For Omlonti For Primary Open-Angle Glaucoma](https://glaucoma.org/wp-content/uploads/2023/11/fda-approved-stamp_900-585x540.jpg)
Santen Receives FDA Approval for Omlonti for Primary Open-Angle Glaucoma
The new glaucoma eye drop medication increases drainage through the eye’s conventional outflow pathways via a unique pharmacological action.
![Collaborative Research Is Speeding Progress Toward A Cure 6 Can Diet Affect Glaucoma?](https://glaucoma.org/wp-content/uploads/2023/11/diet-greens-berries_900-585x540.jpg)
Can Diet Affect Glaucoma?
Although no studies prove a connection between specific foods and glaucoma, it’s safe to assume that your diet and your overall health can affect the disease.
![Collaborative Research Is Speeding Progress Toward A Cure 7 Tips To Minimize The Side Effects Of Glaucoma Medications](https://glaucoma.org/wp-content/uploads/2024/01/tips-minimizing-side-effects_900-585x540.jpg)
Tips To Minimize the Side Effects of Glaucoma Medications
If you are experiencing side effects from your glaucoma medications, learn what you can do to reduce or eliminate them.
![Collaborative Research Is Speeding Progress Toward A Cure 8 Neurodegeneration Explained](https://glaucoma.org/wp-content/uploads/2023/11/questions-and-answers-concept_900-585x540.jpg)
Neurodegeneration Explained
What is neurodegeneration? And how will discoveries related to it affect people with glaucoma?
![Collaborative Research Is Speeding Progress Toward A Cure 9 Meet Renaissance Innovators Ted And Melza Barr](https://glaucoma.org/wp-content/uploads/2023/11/ted-and-melza-barr_900-585x540.jpg)
Meet Renaissance Innovators Ted and Melza Barr
The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration is the inspiration of longtime GRF supporters Ted and Melza Barr.
![Collaborative Research Is Speeding Progress Toward A Cure 10 Catalyst For A Cure: Meet The New Team Of Investigators](https://glaucoma.org/wp-content/uploads/2023/11/cfc4-portraits-montage_900-585x540.jpg)
Catalyst for a Cure: Meet the New Team of Investigators
The Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration.
![Collaborative Research Is Speeding Progress Toward A Cure 11 Fourth Catalyst For A Cure Tackles Neurodegeneration](https://glaucoma.org/wp-content/uploads/2023/11/cfc4-team-900square-with-title_edit3-585x540.jpg)
Fourth Catalyst for a Cure Tackles Neurodegeneration
Made possible by visionary donors, Glaucoma Research Foundation’s latest research initiative targets the shared roots of conditions that occur when neurons deteriorate and die.
![Collaborative Research Is Speeding Progress Toward A Cure 12 Catalyst For A Cure: A Synergistic Approach To Scientific Research](https://glaucoma.org/wp-content/uploads/2023/11/cfc-graphic-collaboration-585x540.jpg)
Catalyst for a Cure: A Synergistic Approach to Scientific Research
Dr. John G. Flanagan discusses recent discoveries that could cure glaucoma based on key research accomplishments from 20 years of Catalyst for a Cure.
![Collaborative Research Is Speeding Progress Toward A Cure 13 Study: Black Glaucoma Patients Six Times More Likely To Have Advanced Vision Loss Than White Patients](https://glaucoma.org/wp-content/uploads/2023/11/senior-african-american-man-on-phone_900-585x540.jpg)
Study: Black Glaucoma Patients Six Times More Likely to Have Advanced Vision Loss than White Patients
A study by US researchers compared levels of sight loss in patients with a new diagnosis of primary open-angle glaucoma.
![Collaborative Research Is Speeding Progress Toward A Cure 14 “Solving Neurodegeneration” White Paper Publication Results From Innovative Research Collaboration](https://glaucoma.org/wp-content/uploads/2024/01/neurons-illustration_900b-585x540.jpg)
“Solving Neurodegeneration” White Paper Publication Results from Innovative Research Collaboration
Research paper summarizes the most important common elements that characterize progression in neurodegeneration and hope for new therapies to help patients with these devastating diseases.
![Collaborative Research Is Speeding Progress Toward A Cure 15 Glaukos Receives Fda 510(K) Clearance Of The Istent Infinite Migs Device](https://glaucoma.org/wp-content/uploads/2023/11/doctor-with-model-of-eye-consults-with-patient-in-his-office_900-585x540.jpg)
Glaukos Receives FDA 510(k) Clearance of the iStent Infinite MIGS Device
MIGS founder announces the first-ever micro-invasive implantable device for standalone glaucoma treatment.
![Collaborative Research Is Speeding Progress Toward A Cure 16 Protecting Retinal Ganglion Cells](https://glaucoma.org/wp-content/uploads/2023/11/retinal-ganglion-cell-3d-illustration_900-585x540.jpg)
Protecting Retinal Ganglion Cells
This article summarizes published findings from Catalyst for a Cure (CFC1) research scientists and subsequent discoveries by Dr. Rebecca Sappington’s lab at Vanderbilt and Wake Forest.
![Collaborative Research Is Speeding Progress Toward A Cure 17 Endoscopic Laser Treatment](https://glaucoma.org/wp-content/uploads/2024/01/ecp-probe-image_900-585x540.jpg)
Endoscopic Laser Treatment
Endoscopic laser surgery is used to treat both open-angle and angle-closure glaucoma.
![Collaborative Research Is Speeding Progress Toward A Cure 18 Can Working On A Computer Affect My Glaucoma?](https://glaucoma.org/wp-content/uploads/2023/11/digital-eye-strain_900-585x540.jpg)
Can Working on a Computer Affect My Glaucoma?
No strong evidence suggests excessive use of digital technology is a glaucoma risk factor. However, prolonged computer, tablet, cell phone, and other digital device use can lead to eye strain.
![Collaborative Research Is Speeding Progress Toward A Cure 19 I’M Allergic To My Glaucoma Eye Drops. Is This Common?](https://glaucoma.org/wp-content/uploads/2023/11/man-holding-eye-drops-bottle_900-585x540.jpg)
I’m Allergic to My Glaucoma Eye Drops. Is This Common?
While it’s uncommon for people to have an allergic reaction to eye drops, it can happen.
![Collaborative Research Is Speeding Progress Toward A Cure 20 The Robert N. Shaffer Glaucoma Lecture](https://glaucoma.org/wp-content/uploads/2024/01/2021-shaffer-lecture-at-aao_900-585x540.jpg)
The Robert N. Shaffer Glaucoma Lecture
Since 1980, the American Academy of Ophthalmology has presented a named lecture in honor of pioneering glaucoma specialist Robert N. Shaffer, MD in conjunction with their annual meeting.
![Collaborative Research Is Speeding Progress Toward A Cure 21 When People With Glaucoma Should Avoid Allergy And Decongestant Medications](https://glaucoma.org/wp-content/uploads/2023/11/allergy-medications-in-womans-hand_900-585x540.jpg)
When People With Glaucoma Should Avoid Allergy and Decongestant Medications
Some allergy medications include ingredients that can cause pupil dilation resulting in a condition called acute angle-closure glaucoma.
![Collaborative Research Is Speeding Progress Toward A Cure 22 What Is Considered Normal Eye Pressure?](https://glaucoma.org/wp-content/uploads/2023/11/elderly-lady-eye-exam_900-585x540.jpg)
What Is Considered Normal Eye Pressure?
Eye pressure can vary hourly, daily, and weekly. Measuring your intraocular pressure (IOP) during eye exams provides an important indication of your eye health.
![Collaborative Research Is Speeding Progress Toward A Cure 23 Can Exercise Lower Eye Pressure?](https://glaucoma.org/wp-content/uploads/2024/01/walking-jogging_900-585x540.jpg)
Can Exercise Lower Eye Pressure?
Exercise for glaucoma patients can be beneficial. Research has shown that regular exercise lowers intraocular pressure (IOP) in glaucoma patients.
![Collaborative Research Is Speeding Progress Toward A Cure 24 Pilot Project Grants Fill Critical Gap](https://glaucoma.org/wp-content/uploads/2023/11/pilot-project-research-grants-scientist_900-585x540.jpg)
Pilot Project Grants Fill Critical Gap
Pilot project grants support new and promising ideas in the field of glaucoma research.
![Collaborative Research Is Speeding Progress Toward A Cure 25 Collaborative Research Is Speeding Progress Toward A Cure](https://glaucoma.org/wp-content/uploads/2023/11/cfc-researchers-stanford-lab_900-585x540.jpg)
Collaborative Research is Speeding Progress toward a Cure
When Glaucoma Research Foundation first launched Catalyst for a Cure in 2002, our bold idea was to recruit the most promising young researchers from different fields to work collaboratively.